HEADER STRUCTURAL PROTEIN 09-OCT-18 6MQ5 TITLE STRUCTURE OF HUMAN CLASP1 TOG1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CLIP-ASSOCIATING PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 1,MULTIPLE ASTERS COMPND 5 HOMOLOG 1,PROTEIN ORBIT HOMOLOG 1,HORBIT1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLASP1, KIAA0622, MAST1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MICROTUBULE PLUS END BINDING, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.B.LEANO,K.C.SLEP REVDAT 3 01-JAN-20 6MQ5 1 REMARK REVDAT 2 31-JUL-19 6MQ5 1 JRNL REVDAT 1 17-JUL-19 6MQ5 0 JRNL AUTH J.B.LEANO,K.C.SLEP JRNL TITL STRUCTURES OF TOG1 AND TOG2 FROM THE HUMAN MICROTUBULE JRNL TITL 2 DYNAMICS REGULATOR CLASP1. JRNL REF PLOS ONE V. 14 19823 2019 JRNL REFN ESSN 1932-6203 JRNL PMID 31323070 JRNL DOI 10.1371/JOURNAL.PONE.0219823 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14_3211: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.95 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.2 REMARK 3 NUMBER OF REFLECTIONS : 21035 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.180 REMARK 3 FREE R VALUE TEST SET COUNT : 1931 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.9509 - 5.1658 1.00 1504 154 0.1700 0.1918 REMARK 3 2 5.1658 - 4.1028 0.99 1499 152 0.1595 0.2006 REMARK 3 3 4.1028 - 3.5849 0.99 1487 152 0.1616 0.2041 REMARK 3 4 3.5849 - 3.2574 0.98 1471 151 0.1806 0.2411 REMARK 3 5 3.2574 - 3.0241 0.97 1461 147 0.2061 0.2822 REMARK 3 6 3.0241 - 2.8459 0.95 1418 146 0.2191 0.2849 REMARK 3 7 2.8459 - 2.7035 0.93 1369 139 0.2279 0.3025 REMARK 3 8 2.7035 - 2.5858 0.91 1352 136 0.2127 0.2912 REMARK 3 9 2.5858 - 2.4863 0.88 1335 132 0.1952 0.2617 REMARK 3 10 2.4863 - 2.4005 0.88 1302 130 0.1984 0.2209 REMARK 3 11 2.4005 - 2.3255 0.86 1274 129 0.2039 0.2862 REMARK 3 12 2.3255 - 2.2590 0.86 1303 131 0.2139 0.2850 REMARK 3 13 2.2590 - 2.1996 0.80 1200 119 0.2325 0.2936 REMARK 3 14 2.1996 - 2.1459 0.76 1129 113 0.2479 0.3434 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.970 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 3732 REMARK 3 ANGLE : 1.381 5030 REMARK 3 CHIRALITY : 0.223 585 REMARK 3 PLANARITY : 0.006 650 REMARK 3 DIHEDRAL : 16.055 1434 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6MQ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1000237292. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97964 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 300 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41883 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.146 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.960 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: AUTOSOL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: EQUAL VOLUME OF 10 MG/ML HCLASP1 TOG1 REMARK 280 AND WELL SOLUTION CONTAINING 30% PEG600, 100MM MES, PH 6.5, 10% REMARK 280 GLYCEROL WERE MIXED TOGETHER AND EQUILIBRATED OVER 1 ML OF WELL REMARK 280 SOLUTION, CRYSTALS THAT WERE ORIGINALLY CRYSTALLIZED IN 1.5 M REMARK 280 SODIUM MALONATE, PH 6.25, 18C, WERE USED FOR MICROSEEDING, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 57.01100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 235 REMARK 465 ALA A 236 REMARK 465 ASN A 237 REMARK 465 ASP A 238 REMARK 465 LYS A 239 REMARK 465 ASN A 240 REMARK 465 PHE A 241 REMARK 465 ASP A 242 REMARK 465 ASP A 243 REMARK 465 GLU A 244 REMARK 465 ASP A 245 REMARK 465 SER A 246 REMARK 465 VAL A 247 REMARK 465 ASP A 248 REMARK 465 GLY A 249 REMARK 465 ASN A 250 REMARK 465 ARG A 251 REMARK 465 PRO A 252 REMARK 465 SER A 253 REMARK 465 SER A 254 REMARK 465 ALA A 255 REMARK 465 SER A 256 REMARK 465 SER A 257 REMARK 465 SER B 235 REMARK 465 ALA B 236 REMARK 465 ASN B 237 REMARK 465 ASP B 238 REMARK 465 LYS B 239 REMARK 465 ASN B 240 REMARK 465 PHE B 241 REMARK 465 ASP B 242 REMARK 465 ASP B 243 REMARK 465 GLU B 244 REMARK 465 ASP B 245 REMARK 465 SER B 246 REMARK 465 VAL B 247 REMARK 465 ASP B 248 REMARK 465 GLY B 249 REMARK 465 ASN B 250 REMARK 465 ARG B 251 REMARK 465 PRO B 252 REMARK 465 SER B 253 REMARK 465 SER B 254 REMARK 465 ALA B 255 REMARK 465 SER B 256 REMARK 465 SER B 257 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLY B 101 C ASP B 102 N 0.168 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 82 -123.55 48.98 REMARK 500 ALA A 123 -130.13 -149.14 REMARK 500 ILE A 233 -74.53 -106.91 REMARK 500 GLN B 82 -121.63 46.14 REMARK 500 ALA B 123 -129.32 -146.23 REMARK 500 ILE B 233 46.96 -62.40 REMARK 500 REMARK 500 REMARK: NULL DBREF 6MQ5 A 1 257 UNP Q7Z460 CLAP1_HUMAN 1 257 DBREF 6MQ5 B 1 257 UNP Q7Z460 CLAP1_HUMAN 1 257 SEQRES 1 A 257 MSE GLU PRO ARG MSE GLU SER CYS LEU ALA GLN VAL LEU SEQRES 2 A 257 GLN LYS ASP VAL GLY LYS ARG LEU GLN VAL GLY GLN GLU SEQRES 3 A 257 LEU ILE ASP TYR PHE SER ASP LYS GLN LYS SER ALA ASP SEQRES 4 A 257 LEU GLU HIS ASP GLN THR MSE LEU ASP LYS LEU VAL ASP SEQRES 5 A 257 GLY LEU ALA THR SER TRP VAL ASN SER SER ASN TYR LYS SEQRES 6 A 257 VAL VAL LEU LEU GLY MSE ASP ILE LEU SER ALA LEU VAL SEQRES 7 A 257 THR ARG LEU GLN ASP ARG PHE LYS ALA GLN ILE GLY THR SEQRES 8 A 257 VAL LEU PRO SER LEU ILE ASP ARG LEU GLY ASP ALA LYS SEQRES 9 A 257 ASP SER VAL ARG GLU GLN ASP GLN THR LEU LEU LEU LYS SEQRES 10 A 257 ILE MSE ASP GLN ALA ALA ASN PRO GLN TYR VAL TRP ASP SEQRES 11 A 257 ARG MSE LEU GLY GLY PHE LYS HIS LYS ASN PHE ARG THR SEQRES 12 A 257 ARG GLU GLY ILE CYS LEU CYS LEU ILE ALA THR LEU ASN SEQRES 13 A 257 ALA SER GLY ALA GLN THR LEU THR LEU SER LYS ILE VAL SEQRES 14 A 257 PRO HIS ILE CYS ASN LEU LEU GLY ASP PRO ASN SER GLN SEQRES 15 A 257 VAL ARG ASP ALA ALA ILE ASN SER LEU VAL GLU ILE TYR SEQRES 16 A 257 ARG HIS VAL GLY GLU ARG VAL ARG ALA ASP LEU SER LYS SEQRES 17 A 257 LYS GLY LEU PRO GLN SER ARG LEU ASN VAL ILE PHE THR SEQRES 18 A 257 LYS PHE ASP GLU VAL GLN LYS SER GLY ASN MSE ILE GLN SEQRES 19 A 257 SER ALA ASN ASP LYS ASN PHE ASP ASP GLU ASP SER VAL SEQRES 20 A 257 ASP GLY ASN ARG PRO SER SER ALA SER SER SEQRES 1 B 257 MSE GLU PRO ARG MSE GLU SER CYS LEU ALA GLN VAL LEU SEQRES 2 B 257 GLN LYS ASP VAL GLY LYS ARG LEU GLN VAL GLY GLN GLU SEQRES 3 B 257 LEU ILE ASP TYR PHE SER ASP LYS GLN LYS SER ALA ASP SEQRES 4 B 257 LEU GLU HIS ASP GLN THR MSE LEU ASP LYS LEU VAL ASP SEQRES 5 B 257 GLY LEU ALA THR SER TRP VAL ASN SER SER ASN TYR LYS SEQRES 6 B 257 VAL VAL LEU LEU GLY MSE ASP ILE LEU SER ALA LEU VAL SEQRES 7 B 257 THR ARG LEU GLN ASP ARG PHE LYS ALA GLN ILE GLY THR SEQRES 8 B 257 VAL LEU PRO SER LEU ILE ASP ARG LEU GLY ASP ALA LYS SEQRES 9 B 257 ASP SER VAL ARG GLU GLN ASP GLN THR LEU LEU LEU LYS SEQRES 10 B 257 ILE MSE ASP GLN ALA ALA ASN PRO GLN TYR VAL TRP ASP SEQRES 11 B 257 ARG MSE LEU GLY GLY PHE LYS HIS LYS ASN PHE ARG THR SEQRES 12 B 257 ARG GLU GLY ILE CYS LEU CYS LEU ILE ALA THR LEU ASN SEQRES 13 B 257 ALA SER GLY ALA GLN THR LEU THR LEU SER LYS ILE VAL SEQRES 14 B 257 PRO HIS ILE CYS ASN LEU LEU GLY ASP PRO ASN SER GLN SEQRES 15 B 257 VAL ARG ASP ALA ALA ILE ASN SER LEU VAL GLU ILE TYR SEQRES 16 B 257 ARG HIS VAL GLY GLU ARG VAL ARG ALA ASP LEU SER LYS SEQRES 17 B 257 LYS GLY LEU PRO GLN SER ARG LEU ASN VAL ILE PHE THR SEQRES 18 B 257 LYS PHE ASP GLU VAL GLN LYS SER GLY ASN MSE ILE GLN SEQRES 19 B 257 SER ALA ASN ASP LYS ASN PHE ASP ASP GLU ASP SER VAL SEQRES 20 B 257 ASP GLY ASN ARG PRO SER SER ALA SER SER MODRES 6MQ5 MSE A 1 MET MODIFIED RESIDUE MODRES 6MQ5 MSE A 5 MET MODIFIED RESIDUE MODRES 6MQ5 MSE A 46 MET MODIFIED RESIDUE MODRES 6MQ5 MSE A 71 MET MODIFIED RESIDUE MODRES 6MQ5 MSE A 119 MET MODIFIED RESIDUE MODRES 6MQ5 MSE A 132 MET MODIFIED RESIDUE MODRES 6MQ5 MSE A 232 MET MODIFIED RESIDUE MODRES 6MQ5 MSE B 1 MET MODIFIED RESIDUE MODRES 6MQ5 MSE B 5 MET MODIFIED RESIDUE MODRES 6MQ5 MSE B 46 MET MODIFIED RESIDUE MODRES 6MQ5 MSE B 71 MET MODIFIED RESIDUE MODRES 6MQ5 MSE B 119 MET MODIFIED RESIDUE MODRES 6MQ5 MSE B 132 MET MODIFIED RESIDUE MODRES 6MQ5 MSE B 232 MET MODIFIED RESIDUE HET MSE A 1 8 HET MSE A 5 8 HET MSE A 46 8 HET MSE A 71 8 HET MSE A 119 8 HET MSE A 132 8 HET MSE A 232 8 HET MSE B 1 8 HET MSE B 5 8 HET MSE B 46 8 HET MSE B 71 8 HET MSE B 119 8 HET MSE B 132 8 HET MSE B 232 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 14(C5 H11 N O2 SE) FORMUL 3 HOH *183(H2 O) HELIX 1 AA1 ARG A 4 GLN A 14 1 11 HELIX 2 AA2 ASP A 16 ASP A 33 1 18 HELIX 3 AA3 ASP A 43 SER A 57 1 15 HELIX 4 AA4 ASN A 63 GLN A 82 1 20 HELIX 5 AA5 PHE A 85 LEU A 100 1 16 HELIX 6 AA6 LYS A 104 ALA A 122 1 19 HELIX 7 AA7 ASN A 124 ARG A 131 1 8 HELIX 8 AA8 MSE A 132 HIS A 138 5 7 HELIX 9 AA9 ASN A 140 GLY A 159 1 20 HELIX 10 AB1 ALA A 160 LEU A 163 5 4 HELIX 11 AB2 THR A 164 GLY A 177 1 14 HELIX 12 AB3 ASN A 180 GLY A 199 1 20 HELIX 13 AB4 GLY A 199 LYS A 208 1 10 HELIX 14 AB5 PRO A 212 SER A 229 1 18 HELIX 15 AB6 ARG B 4 GLN B 14 1 11 HELIX 16 AB7 ASP B 16 ASP B 33 1 18 HELIX 17 AB8 ASP B 43 SER B 57 1 15 HELIX 18 AB9 ASN B 63 GLN B 82 1 20 HELIX 19 AC1 ASP B 83 ALA B 87 5 5 HELIX 20 AC2 GLN B 88 LEU B 100 1 13 HELIX 21 AC3 LYS B 104 ALA B 122 1 19 HELIX 22 AC4 ASN B 124 ARG B 131 1 8 HELIX 23 AC5 MSE B 132 HIS B 138 5 7 HELIX 24 AC6 ASN B 140 GLY B 159 1 20 HELIX 25 AC7 ALA B 160 LEU B 163 5 4 HELIX 26 AC8 THR B 164 LEU B 176 1 13 HELIX 27 AC9 ASN B 180 GLY B 199 1 20 HELIX 28 AD1 GLU B 200 LYS B 208 1 9 HELIX 29 AD2 PRO B 212 GLY B 230 1 19 LINK C MSE A 1 N GLU A 2 1555 1555 1.34 LINK C ARG A 4 N MSE A 5 1555 1555 1.33 LINK C MSE A 5 N GLU A 6 1555 1555 1.33 LINK C THR A 45 N MSE A 46 1555 1555 1.33 LINK C MSE A 46 N LEU A 47 1555 1555 1.33 LINK C GLY A 70 N MSE A 71 1555 1555 1.32 LINK C MSE A 71 N ASP A 72 1555 1555 1.33 LINK C ILE A 118 N MSE A 119 1555 1555 1.34 LINK C MSE A 119 N ASP A 120 1555 1555 1.33 LINK C ARG A 131 N MSE A 132 1555 1555 1.33 LINK C MSE A 132 N LEU A 133 1555 1555 1.33 LINK C ASN A 231 N MSE A 232 1555 1555 1.33 LINK C MSE A 232 N ILE A 233 1555 1555 1.33 LINK C MSE B 1 N GLU B 2 1555 1555 1.34 LINK C ARG B 4 N MSE B 5 1555 1555 1.33 LINK C MSE B 5 N GLU B 6 1555 1555 1.33 LINK C THR B 45 N MSE B 46 1555 1555 1.33 LINK C MSE B 46 N LEU B 47 1555 1555 1.33 LINK C GLY B 70 N MSE B 71 1555 1555 1.33 LINK C MSE B 71 N ASP B 72 1555 1555 1.34 LINK C ILE B 118 N MSE B 119 1555 1555 1.33 LINK C MSE B 119 N ASP B 120 1555 1555 1.34 LINK C ARG B 131 N MSE B 132 1555 1555 1.32 LINK C MSE B 132 N LEU B 133 1555 1555 1.33 LINK C ASN B 231 N MSE B 232 1555 1555 1.33 LINK C MSE B 232 N ILE B 233 1555 1555 1.33 CRYST1 40.975 114.022 46.649 90.00 99.85 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024405 0.000000 0.004237 0.00000 SCALE2 0.000000 0.008770 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021757 0.00000 HETATM 1 N MSE A 1 6.560 38.677 37.578 1.00 51.49 N HETATM 2 CA MSE A 1 7.211 38.227 36.345 1.00 55.58 C HETATM 3 C MSE A 1 8.739 38.271 36.446 1.00 59.65 C HETATM 4 O MSE A 1 9.295 38.250 37.548 1.00 64.54 O HETATM 5 CB MSE A 1 6.745 39.068 35.145 1.00 58.57 C HETATM 6 CG MSE A 1 6.903 40.589 35.307 1.00 65.62 C HETATM 7 SE MSE A 1 6.736 41.617 33.624 1.00 83.25 SE HETATM 8 CE MSE A 1 6.646 43.430 34.349 1.00 70.08 C